When should 'Plt' (platelet count) versus 'Plt F' (flagged platelet count) be reported to the healthcare provider in Sysmex hematology results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reporting Platelet Counts on Sysmex Hematology Analyzers

Report PLT-F (fluorescence channel) to providers when available, as it provides superior accuracy compared to standard PLT-I (impedance channel), particularly in thrombocytopenic and abnormal samples where clinical decisions about transfusion thresholds are critical.

Understanding the Two Measurement Methods

PLT-I (Impedance Method)

  • Uses electrical impedance to count particles based on size 1, 2
  • Cost-effective and standard on most analyzers 3
  • Susceptible to interference from small red blood cells, red cell fragments (schistocytes), white blood cell fragments, and other non-platelet particles 1, 3, 2
  • Can produce falsely elevated counts in anemic and thrombocytopenic samples 3, 4

PLT-F (Fluorescence Method)

  • Uses fluorescent dye that specifically stains intraplatelet organelles (particularly those labeled with anti-Grp75) while only faintly staining cell membranes 1
  • Clearly distinguishes platelets from fragmented erythrocytes through specific staining properties 1
  • All strongly stained cells are confirmed to be platelet-specific (CD41+ and CD61+) 1
  • Provides superior accuracy in abnormal samples including those from burn injury, acute leukemia, and severe aplastic anemia 5, 2

When PLT-F is Essential

Critical clinical scenarios where PLT-F should be reported:

  • Thrombocytopenic samples (PLT <50 × 10⁹/L): PLT-F reduces falsely elevated results by nearly fivefold compared to PLT-I 3
  • Anemic patients: PLT-F shows excellent correlation (0.991-0.999) with reference methods across all types of anemia 3
  • Patients with hemolysis: Ghost cells and spiny cells from hemolysis interfere with PLT-I but not PLT-F 5
  • Hematologic malignancies: White blood cell fragments in acute leukemia samples interfere with PLT-I 2
  • Burn injury patients: Red cell fragments cause spurious PLT-I elevations 2

Clinical Decision Thresholds

Understanding when platelet counts matter for bleeding risk:

  • 50 × 10⁹/L threshold: Significant for immediate post-procedural bleeding risk (OR = 6.6 for procedures like polypectomy; OR = 8.79 for percutaneous ablation) 6
  • Transfusion decisions: Generally recommended to maintain >50 × 10⁹/L in ongoing bleeding 7
  • Higher-risk procedures: Target >100 × 10⁹/L for traumatic brain injury or critical conditions 7

Practical Reporting Algorithm

Follow this decision tree:

  1. If PLT-F is available on your analyzer → Report PLT-F as the primary platelet count 1, 3, 2

  2. If only PLT-I is available:

    • Report PLT-I for normal samples (no flags, normal histogram)
    • Flag for manual review if: thrombocytopenia, anemia, hemolysis, hematologic malignancy, or any PLT flags present 5, 2
    • Perform microscopic platelet estimation using platelet-to-RBC ratio in flagged samples 5
  3. If PLT-I and PLT-F are discordant:

    • Prioritize PLT-F as the accurate count 3, 2, 4
    • PLT-I typically overestimates in these cases 3, 4

Common Pitfalls to Avoid

  • Do not assume normal histograms guarantee accuracy: Spurious high platelet counts can occur without PLT flags or abnormal histograms in special hematologic patients 5
  • Do not rely solely on PLT-I in thrombocytopenic samples: At counts ≤2.0 × 10⁹/L, PLT-F shows better reproducibility than PLT-I 4
  • Do not ignore discordant results at transfusion thresholds: In 41 discordant samples near transfusion cutoffs, PLT-I (optical equivalent) showed higher counts than PLT-F in all but one case, potentially delaying necessary transfusions 4

Reproducibility Considerations

  • PLT-F exceeds desirable precision criteria (7.6%) in 60% of severely thrombocytopenic samples (≤2.0 × 10⁹/L) 4
  • PLT-I optical methods exceed precision criteria in only 10% of the same samples 4
  • For critical decisions in severe thrombocytopenia, consider repeat testing or manual verification 5, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.